David L. Lucchino - 17 Feb 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)

Role
President and CEO, Director
Signature
/s/ James P. Abely, Attorney-in-Fact for David L. Lucchino
Issuer symbol
KRRO
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
18 Feb 2022, 15:18:31 UTC
Previous filing
20 Jan 2022
Next filing
19 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Restricted Stock Unit Award $0 +300,000 $0.000000 300,000 17 Feb 2022 Common Stock 300,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive on share of Issuer common stock.
F2 The restricted stock units will fully vest on July 4, 2023.